BIRC5 and cancer: It has been previously argued that detection of Survivin expression may independently predict a worse outcome only in specific subgroups of patients with early stage-cancer (Sarela, 2000) and this may partly explain the absence of prognostic function for Survivin in this series of locally advanced pancreatic adenocarcinoma.